The Antiretroviral nelfinavir mesylate, a potential therapy for systemic scleroderma

25th September 2017 Uncategorised 0

Arthritis & Rheumatism

More: The Antiretroviral nelfinavir mesylate, a potential therapy for systemic scleroderma
Source: MDlinx